Curis Inc (CRIS)
3.46
-0.27
(-7.24%)
USD |
NASDAQ |
Jan 08, 16:00
3.46
0.00 (0.00%)
After-Hours: 04:54
Curis Profit Margin (Quarterly): -344.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -461.3% |
| Return on Assets | -70.59% |
| Return on Invested Capital | -461.3% |
| Gross Profit Margin (Quarterly) | 99.25% |
| Operating Margin (Quarterly) | -360.5% |
| Return on Net Operating Assets | -297.4% |